$100 Invested In United Therapeutics 15 Years Ago Would Be Worth This Much Today
Benzinga Insights 3 weeks ago
Trading IdeasNews
United Therapeutics (NASDAQ:UTHR) has outperformed the market over the past 15 years by 6.41% on an annualized basis producing an average annual return of 19.23%. Currently, United Therapeutics has a market
United Therapeutics (NASDAQ:UTHR) has outperformed the market over the past 15 years by 6.41% on an annualized basis producing an average annual return of 19.23%. Currently, United Therapeutics has a market capitalization of $25.36 billion.
Buying $100 In UTHR: If an investor had bought $100 of UTHR stock 15 years ago, it would be worth $1,430.06 today based on a price of $586.30 for UTHR at the time of writing.
United Therapeutics’s Performance Over Last 15 Years

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
More on UTHR
Benzinga
United Therapeutics Announces First Clinical Xenotransplant In Its EXTEND Study Of UThymoKidney In Patients With ESRDThe EXTEND study is the first clinical trial to evaluate xenotransplantation of a porcine thymokidney in a patient with end-stage renal disease (ESRD)EXTEND is the second clinical trial in United…
